monoclonal antibody discovery and development

Aridis Pharmaceuticals, Inc. is a late-stage clinical development biopharmaceutical company focused on developing novel, differentiated therapies for infectious diseases, including first-in-class anti-infectives for life-threatening viral and bacterial respiratory infections. Its pipeline includes therapeutic monoclonal antibodies and novel anti-infectives derived from its proprietary technology platforms.

Read more

clinical developmentdrug developmentMabIgX technology platform⅄PEX technology platform